[Advances in the treatment of Clostridium difficile infection in children]. / å¿ç«¥è°é¾æ¢èææçæ²»çè¿å±.
Zhongguo Dang Dai Er Ke Za Zhi
; 26(9): 995-1001, 2024.
Article
en Zh
| MEDLINE
| ID: mdl-39267518
ABSTRACT
Clostridium difficile infection (CDI) is a major cause of hospital-acquired gastrointestinal infections in children. Current treatment for pediatric CDI primarily involves antibiotics; however, some children experience recurrence after antibiotic treatment, and those with initial recurrence remain at risk for further recurrences following subsequent antibiotic therapy. In such cases, careful consideration of treatment options is necessary. Fecal microbiota transplantation has been shown to be effective for recurrent CDI and has a high safety profile. This article reviews the latest research on the pathogenesis, risk factors, diagnosis, and treatment of pediatric CDI domestically and internationally, with a particular focus on fecal microbiota transplantation therapy.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Infecciones por Clostridium
/
Trasplante de Microbiota Fecal
Límite:
Child
/
Humans
Idioma:
Zh
Revista:
Zhongguo Dang Dai Er Ke Za Zhi
Año:
2024
Tipo del documento:
Article
Pais de publicación:
China